Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1122340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Lydia C Powell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom. Hauptthemen laut MEDLINE: Antifungal Agents, Candidiasis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, European Social Fund, European Regional Development Fund.
Abstract (Originalsprache)
Background
The increasing prevalence of invasive fungal infections in immuno-compromised patients is a considerable cause of morbidity and mortality. With the rapid emergence of antifungal resistance and an inadequate pipeline of new therapies, novel treatment strategies are now urgently required.
Methods
The antifungal activity of the alginate oligosaccharide OligoG in conjunction with nystatin was tested against a range of Candida spp. ( C. albicans , C. glabrata , C. parapsilosis , C. auris , C. tropicalis and C. dubliniensis ), in both planktonic and biofilm assays, to determine its potential clinical utility to enhance the treatment of candidal infections. The effect of OligoG (0-6%) ± nystatin on Candida spp. was examined in minimum inhibitory concentration (MIC) and growth curve assays. Antifungal effects of OligoG and nystatin treatment on biofilm formation and disruption were characterized using confocal laser scanning microscopy (CLSM), scanning electron microscopy (SEM) and ATP cellular viability assays. Effects on the cell membrane were determined using permeability assays and transmission electron microscopy (TEM).
Results
MIC and growth curve assays demonstrated the synergistic effects of OligoG (0-6%) with nystatin, resulting in an up to 32-fold reduction in MIC, and a significant reduction in the growth of C. parapsilosis and C. auris (minimum significant difference = 0.2 and 0.12 respectively). CLSM and SEM imaging demonstrated that the combination treatment of OligoG (4%) with nystatin (1 µg/ml) resulted in significant inhibition of candidal biofilm formation on glass and clinical grade silicone surfaces ( p < 0.001), with increased cell death ( p < 0.0001). The ATP biofilm disruption assay demonstrated a significant reduction in cell viability with OligoG (4%) alone and the combined OligoG/nystatin (MIC value) treatment ( p < 0.04) for all Candida strains tested. TEM studies revealed the combined OligoG/nystatin treatment induced structural reorganization of the Candida cell membrane, with increased permeability when compared to the untreated control ( p < 0.001).
Conclusions
Antimicrobial synergy between OligoG and nystatin against Candida spp. highlights the potential utility of this combination therapy in the prevention and topical treatment of candidal biofilm infections, to overcome the inherent tolerance of biofilm structures to antifungal agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
- Microbiology and Infectious Disease group, Swansea University Medical School, Swansea, United Kingdom.
- Otolaryngology Department, New Cross Hospital, Wolverhampton, United Kingdom.
- School of Engineering, University of Angers, Angers, France.
- Centre for Nanohealth, Swansea University Medical School, Swansea, United Kingdom.
- Central Biotechnology Services, Cardiff University School of Medicine, Cardiff, United Kingdom.
Förderung
- Norges Forskningsråd
- European Social Fund
- European Regional Development Fund
- AlgiPharma
Zitieren
APA
Powell, L. C., Adams, J. Y. M., Quoraishi, S., Py, C., Oger, A., Gazze, S. A., Francis, L. W., von Ruhland, C., Owens, D., Rye, P. D., Hill, K. E., Pritchard, M. F., & Thomas, D. W. (2023). Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1122340
Vancouver
Powell LC, Adams JYM, Quoraishi S, Py C, Oger A, Gazze SA, et al. Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1122340
BibTeX
@article{Powell2023,
author = {Powell, Lydia C and Adams, Jennifer Y M and Quoraishi, Sadik and Py, Charlène and Oger, Anaϊs and Gazze, Salvatore A and Francis, Lewis W and von Ruhland, Christopher and Owens, David and Rye, Philip D and Hill, Katja E and Pritchard, Manon F and Thomas, David W},
title = {Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1122340}
}
EUVIMED